Implementation of Pharmacogenetic Testing in Hospital Wards
NCT ID: NCT04573491
Last Updated: 2023-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2020-10-05
2021-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting
NCT02937545
Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)
NCT03322189
Effect of Medication Reviews Performed in High Risk Patients
NCT01819974
Patient Pathway Pharmacist - Optimal Drug-related Care
NCT03695081
Pharmacogenetic Testing Among Home Health Patients
NCT02378220
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The use of pharmacogenetic testing as part of medication reviews has not earlier been systematically investigated in hospital patients in Norway. There is little documentation of what is needed to implement the use of pharmacogenetic testing in a hospital ward.
The investigators are conducting a descriptive study in two internal medicine wards at Akershus University Hospital. 50 patients using minimum 5 regular drugs including at least one relevant for pharmacogenetic testing will be enrolled in the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pharmacogenetic test
Medication review including results from pharmacogenetic testing
Pharmacogenetic test
genotyping for genes that affect drug metabolism
Medication review
systematic and interdisciplinary method aiming to increase quality of medication treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmacogenetic test
genotyping for genes that affect drug metabolism
Medication review
systematic and interdisciplinary method aiming to increase quality of medication treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* at least 5 regular drugs of which at least one relevant for pharmacogenetic testing
* at least 2 years life expectancy
* able to communicate in Norwegian
* able to give informed consent
* summary care record
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Akershus
OTHER
Diakonhjemmet Hospital
OTHER
University of Oslo School of Pharmacy
OTHER
Hospital Pharmacy Enterprise, South Eastern Norway
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathrin Bjerknes, Ph.D
Role: STUDY_DIRECTOR
Hospital Pharmacy Enterprise, South Eastern Norway
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akershus University Hospital
Lørenskog, Nordbyhagen, Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hjemas BJ, Bovre K, Bjerknes K, Mathiesen L, Mellingsaeter MCR, Molden E. Implementation of pharmacogenetic testing in medication reviews in a hospital setting. Br J Clin Pharmacol. 2023 Oct;89(10):3116-3125. doi: 10.1111/bcp.15815. Epub 2023 Jun 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMP-CYP SA HF 2020-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.